Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
NYSE - Delayed Quote USD

Guardian Pharmacy Services, Inc. (GRDN)

Compare
20.00
+1.53
+(8.28%)
At close: February 28 at 4:00:02 PM EST
18.01
-1.99
(-9.95%)
Pre-Market: 4:09:51 AM EST
Loading Chart for GRDN
DELL
  • Previous Close 18.47
  • Open 18.47
  • Bid --
  • Ask --
  • Day's Range 18.27 - 20.19
  • 52 Week Range 14.16 - 25.74
  • Volume 55,407
  • Avg. Volume 137,943
  • Market Cap (intraday) 1.266B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -1.38
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 24.33

Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company's Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs. The company was founded in 2003 and is based in Atlanta, Georgia.

guardianpharmacy.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: GRDN

View More

Performance Overview: GRDN

Trailing total returns as of 2/28/2025, which may include dividends or other distributions. Benchmark is S&P 500 .

YTD Return

GRDN
1.28%
S&P 500
1.24%

1-Year Return

GRDN
38.31%
S&P 500
17.45%

3-Year Return

GRDN
38.31%
S&P 500
36.14%

5-Year Return

GRDN
38.31%
S&P 500
101.56%

Compare To: GRDN

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: GRDN

View More

Valuation Measures

Annual
As of 2/28/2025
  • Market Cap

    1.27B

  • Enterprise Value

    1.30B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.08

  • Price/Book (mrq)

    9.92

  • Enterprise Value/Revenue

    1.11

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -7.45%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    1.17B

  • Net Income Avi to Common (ttm)

    -98.09M

  • Diluted EPS (ttm)

    -1.38

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    37.22M

  • Total Debt/Equity (mrq)

    55.94%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: GRDN

View More

Company Insights: GRDN

Research Reports: GRDN

View More

People Also Watch